Skip to content

Research on tigecycline in postoperative analgesia after prostate surgery

Research on tigecycline in postoperative analgesia after prostate surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120372
Enrollment
Unknown
Registered
2026-03-13
Start date
2026-03-13
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate surgery

Interventions

Experimental group:At the end of surgery, a loading dose of 1 mg of Tigilidine was administered intravenously, and the patient-controlled analgesia (PCA) pump was started immediately. PCA pump setting
Control gruop:At the end of surgery, a loading dose of 3 µg of sufentanil was administered intravenously, and the patient-controlled analgesia (PCA) pump was started immediately. PCA pump settings: co

Sponsors

Shanghai Fengxian District Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 50–85 years scheduled for elective transurethral prostate surgery under general anesthesia; 2. ASA class I–II; 3. Body mass index (BMI) >=18 kg/m^2 or <=30 kg/m^2.

Exclusion criteria

Exclusion criteria: 1. Oxygen saturation 10 days within 3 months prior to randomization; 6. Allergy or contraindication to opioids.

Design outcomes

Primary

MeasureTime frame
Resting AUC24;

Secondary

MeasureTime frame
Overall incidence of urethral pain and incidence of moderate to severe pain within 48 hours postoperatively;;Resting AUC and Cough-induced AUC at 6, 12, and 48 hpostoperatively;;Richmond Agitation-Sedation Scale score;The usage of rescue analgesia;;Number of effective PCA pump demands within 48 hours postoperatively;

Countries

China

Contacts

Public ContactLiu Rong

Shanghai Fengxian District Central Hospital

yaoyuandifang@163.com+86 21 5742 2606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026